Electro-Optic Polymer Developer Lightwave Logic Provides Update

Lightwave Logic, Inc. (OTC Bulletin Board: LWLG) a technology company focused on the development of the 'Next Generation Electro-Optic Polymer Material Platform' for applications in high speed fiber-optic data communications and optical computing, announced the following updates to its shareholders, which will also be announced at its 2010 Annual Meeting of Stockholders.

  1. The company's electro-optic polymers are presently being tested and evaluated by a large system supplier.  We expect results from this system supplier in the near future.
  2. We are awaiting action from the Patent and Trademark Office (PTO) regarding our initial patent filing.  We recently received clarification from the PTO, submitted their requested information on July 1, 2010, and are now awaiting the PTO's action.
  3. We are presently working in conjunction with our university partners on programs that may lead to the development of new commercially viable molecules.
  4. The management presentation from the 2010 Annual Meeting of Stockholders will be posted to the company's website as soon as possible after the meeting.

Source: http://www.lightwavelogic.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.